Coston McIsaac & Partners’s CME Group CME Stock Holding History

Coston McIsaac & Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39K	Hold	179	–	–	0.01%	375
2026 Q1	$52K	Hold	179	–	–	0.01%	317
2025 Q4	$48K	Hold	179	–	–	0.01%	325
2025 Q3	$48K	Hold	179	–	–	0.01%	315
2025 Q2	$49K	Hold	179	–	–	0.01%	298
2025 Q1	$47K	Sell	179 -16	-8%	-$3.95K	0.01%	278
2024 Q4	$45K	Hold	195	–	–	0.01%	294
2024 Q3	$43K	Hold	195	–	–	0.01%	304
2024 Q2	$38K	Sell	195 -100	-34%	-$20.7K	0.01%	305
2024 Q1	$63K	Hold	295	–	–	0.02%	232
2023 Q4	$62K	Buy	295 +16	+6%	+$3.41K	0.02%	226
2023 Q3	$55K	Hold	279	–	–	0.02%	229
2023 Q2	$51K	Hold	279	–	–	0.02%	261
2023 Q1	$53K	Hold	279	–	–	0.02%	250
2022 Q4	$46K	Hold	279	–	–	0.02%	275
2022 Q3	$49K	Hold	279	–	–	0.02%	216
2022 Q2	$57K	Buy	+279	New	+$59.1K	0.03%	125

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Coston McIsaac & Partners's CME Position: Q2 2026 in Review

Coston McIsaac & Partners held its CME Group (CME) position steady in Q2 2026 at 179 shares worth $39K. The position accounts for 0.01% of the portfolio, ranked #375.

Coston McIsaac & Partners first reported a position in CME in Q2 2022 and has held it in 17 quarters since. The position peaked at $63K in Q1 2024. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Coston McIsaac & Partners held 179 shares of CME Group worth $39K as of Q2 2026.
Coston McIsaac & Partners left its CME Group share count unchanged in Q2 2026.
CME Group made up 0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #375 holding.
Coston McIsaac & Partners first reported a position in CME Group in Q2 2022 and has held it in 17 quarters since.
Coston McIsaac & Partners's CME Group position peaked at $63K in Q1 2024.
1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.